ReviewFrontiers in pharmacology2026

Japanese evidence on Janus kinase inhibitors for rheumatoid arthritis: a narrative review of risk-optimized use.

Haruki Matsumoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.